Biofrontera Reports Positive Phase 2b Results for Ameluz® Photodynamic Therapy in Moderate to Severe Acne Vulgaris 1
Biofrontera Inc. Reports Positive Phase 2b Results for Amelu...
Sign in to continue:
Biofrontera Inc. Reports Positive Phase 2b Results for Amelu...
Infinite Eagle Acquisition Corp. Announces Separate Trading ...
Key Highlights Filing of Form 8-K: dMY Squared Technology...
Pulse Biosciences, Inc. Announces Positive Clinical Data for...
Sharplink, Inc. 2025 Annual Report: Key Insights for Investo...
Great Lakes Dredge & Dock Corporation (GLDD) Files 10-K/A: K...
Melar Acquisition Corp. Annual Report: Key Highlights and In...
EVgo Inc. 2025 Annual Report: Key Highlights and Shareholder...
Cumberland Pharmaceuticals 2025 Annual Report – Detailed Inv...
Tri-County Financial Group, Inc. 2025 Annual Report – Key In...